Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26)
Clinical trial NCT06486441 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06486441
- Sponsor
- Gilead Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-28
- Primary completion
- 2029-06-01
- Enrollment
- 640
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.